Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Theriva Biologics Inc (AMEX: TOVX) closed at $0.21 up 5.30% from its previous closing price of $0.2. In other words, the price has increased by $5.30 from its previous closing price. On the day, 1.87 million shares were traded. TOVX stock price reached its highest trading level at $0.2095 during the session, while it also had its lowest trading level at $0.19.
Ratios:
For a deeper understanding of Theriva Biologics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.90 and its Current Ratio is at 0.90. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.31.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOVX now has a Market Capitalization of 6977358 and an Enterprise Value of 2211358.
Stock Price History:
The Beta on a monthly basis for TOVX is 0.36, which has changed by -0.82905984 over the last 52 weeks, in comparison to a change of 0.16081822 over the same period for the S&P500. Over the past 52 weeks, TOVX has reached a high of $2.08, while it has fallen to a 52-week low of $0.19. The 50-Day Moving Average of the stock is -32.67%, while the 200-Day Moving Average is calculated to be -65.44%.
Shares Statistics:
For the past three months, TOVX has traded an average of 15.21M shares per day and 2882840 over the past ten days. A total of 33.74M shares are outstanding, with a floating share count of 32.97M. Insiders hold about 2.27% of the company’s shares, while institutions hold 1.30% stake in the company. Shares short for TOVX as of 1764288000 were 2479067 with a Short Ratio of 0.16, compared to 1761868800 on 1985894. Therefore, it implies a Short% of Shares Outstanding of 2479067 and a Short% of Float of 7.359999999999999.
Earnings Estimates
. The current market rating for Theriva Biologics Inc (TOVX) reflects the collective analysis of 1 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.21 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$2.15 and -$2.15 for the fiscal current year, implying an average EPS of -$2.15. EPS for the following year is -$0.75, with 1.0 analysts recommending between -$0.75 and -$0.75.
